Skip to content

P2Y purinoceptor 12 (P2RY12)

Homo sapiens — UniProt Q9H244

Gene: P2RY12Homo sapiensSwissProt reviewed

Data last refreshed: (UniProt release unknown)

Key facts

P2Y purinoceptor 12 (P2RY12) is a protein from Homo sapiens identified by UniProt accession Q9H244, 342 residues long. MolForge cross-references it against 6 known binders and 391 disease associations.

  • UniProt accession: Q9H244; gene symbol P2RY12.
  • Organism: Homo sapiens.
  • Length: 342 amino acids.
  • Approved drugs acting on it (DrugCentral): Cangrelor, Ticagrelor, Clopidogrel, Prasugrel and Ticlopidine.
  • Top disease associations (Open Targets): platelet-type bleeding disorder 8, P2Y12 defect and myocardial infarction.
  • 3D structure: AlphaFold model available.

Target properties

Protein nameP2Y purinoceptor 12
UniProt accessionQ9H244
GeneP2RY12
OrganismHomo sapiens
Length342 residues
Molecular weight—
EC numbers—
Target class—
Subcellular location—
Keywords—

Druggability

Target tractability assessment (Open Targets + pocket analysis). Approved drug exists

Druggability tierMEDIUM
Druggability score—
Pocket score—
Max clinical phase—

Approved drugs acting on this target (5)

Approved drugs whose DrugCentral mechanism of action is this protein, most potent first.

Disease associations (391)

Diseases linked to this target (Open Targets).

  • platelet-type bleeding disorder 8 · score 0.71
  • P2Y12 defect · score 0.62
  • myocardial infarction · score 0.61
  • coronary artery disease · score 0.61
  • acute coronary syndrome · score 0.61
  • acute myocardial infarction · score 0.61
  • stroke · score 0.60
  • ST Elevation Myocardial Infarction · score 0.59
  • peripheral arterial disease · score 0.59
  • atrial fibrillation · score 0.59

3D Structure (1)

Experimental (PDB) and predicted (AlphaFold) structures for this protein.

StructureSourceMethodMean pLDDTResolution (Å)
AF-Q9H244-F1alphafoldPREDICTED84.46—

Experimental structures are not indexed in MolForge yet — search RCSB PDB for Q9H244.

Amino-acid sequence (342 residues)

MQAVDNLTSA PGNTSLCTRD YKITQVLFPL LYTVLFFVGL ITNGLAMRIF FQIRSKSNFI IFLKNTVISD LLMILTFPFK ILSDAKLGTG PLRTFVCQVT SVIFYFTMYI SISFLGLITI DRYQKTTRPF KTSNPKNLLG AKILSVVIWA FMFLLSLPNM ILTNRQPRDK NVKKCSFLKS EFGLVWHEIV NYICQVIFWI NFLIVIVCYT LITKELYRSY VRTRGVGKVP RKKVNVKVFI IIAVFFICFV PFHFARIPYT LSQTRDVFDC TAENTLFYVK ESTLWLTSLN ACLDPFIYFF LCKSFRNSLI SMLKCPNSAT SLSQDNRKKE QDGGDPNEET PM

Frequently asked questions

Answers are generated from the structured data on this page, not written by hand.

Which approved drugs target P2RY12?

DrugCentral lists 5 approved drugs whose mechanism of action is P2RY12: Cangrelor, Ticagrelor, Clopidogrel, Prasugrel and Ticlopidine.

Which diseases are associated with P2RY12?

The strongest Open Targets associations for P2RY12 are platelet-type bleeding disorder 8, P2Y12 defect, myocardial infarction, coronary artery disease and acute coronary syndrome.

How long is the P2RY12 protein?

The Homo sapiens P2RY12 protein (UniProt Q9H244) is 342 amino acids long.

Browse: Targets: P · all protein targets A–Z · drugs A–Z.

Sources

How this page is built: methodology · editorial policy & corrections.

For research and educational use only — not medical advice. This page is compiled automatically from public databases. It is not written or reviewed by a clinician. Do not start, stop or change any treatment based on it; consult a qualified healthcare professional. Spotted an error? See our corrections policy or email hello@molforge.ai.

Explore P2Y purinoceptor 12 with MolForge

Find binders, run structure-based screening, and map this target across diseases and approved drugs with our AI-powered platform.

Browse all targets

Quick facts

UniProtQ9H244
GeneP2RY12
OrganismHomo sapiens
Length342
Binders6
Diseases391
View on UniProt